Cargando…
Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy
Cholesterol metabolism is often dysregulated in cancer. Squalene monooxygenase (SQLE) is the second rate-limiting enzyme involved in cholesterol synthesis. Since the discovery of SQLE dysregulation in cancer, compelling evidence has indicated that SQLE plays a vital role in cancer initiation and pro...
Autores principales: | Zou, Yuheng, Zhang, Hongying, Bi, Feng, Tang, Qiulin, Xu, Huanji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449579/ https://www.ncbi.nlm.nih.gov/pubmed/36091156 http://dx.doi.org/10.3389/fonc.2022.938502 |
Ejemplares similares
-
Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy
por: Tu, Teng, et al.
Publicado: (2023) -
Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer
por: Xu, Huanji, et al.
Publicado: (2021) -
Hypoxia truncates and constitutively activates the key cholesterol synthesis enzyme squalene monooxygenase
por: Coates, Hudson W, et al.
Publicado: (2023) -
A key mammalian cholesterol synthesis enzyme, squalene monooxygenase, is allosterically stabilized by its substrate
por: Yoshioka, Hiromasa, et al.
Publicado: (2020) -
Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis
por: Ren, Meiling, et al.
Publicado: (2021)